UK secures over 5 million H5 influenza vaccine doses for human use
There is no evidence of human-to-human transmission at this time
3 December 2024
1 minute read
By: Britain's Health Security Agency (UKHSA) said on Tuesday that it has secured a contract for over five million doses of the human H5 influenza vaccine as part of preparations for a potential influenza pandemic, reported Reuters.
The vaccine, which will be produced by the UK healthcare company CSL Seqirus UK Ltd, is intended for use only if the virus begins to spread among humans.
Currently, there is no evidence of such human-to-human transmission, according to the agency.
